Mirae Asset Global Investments’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,121
Closed -$6.51K 1712
2025
Q3
$6.51K Buy
4,121
+14
+0.3% +$24 ﹤0.01% 1601
2025
Q2
$8.95K Buy
4,107
+793
+24% +$1.92K ﹤0.01% 1502
2025
Q1
$9.05K Sell
3,314
-201
-6% -$792 ﹤0.01% 1479
2024
Q4
$14.5K Sell
3,515
-286
-8% -$1.08K ﹤0.01% 1466
2024
Q3
$14.7K Buy
3,801
+680
+22% +$2.87K ﹤0.01% 1472
2024
Q2
$12.5K Sell
3,121
-39,351
-93% -$169K ﹤0.01% 1440
2024
Q1
$174K Buy
+42,472
New +$199K ﹤0.01% 2292
2023
Q4
Sell
-41,830
Closed -$131K 2575
2023
Q3
$131K Buy
41,830
+102
+0.2% +$410 ﹤0.01% 2408
2023
Q2
$192K Sell
41,728
-187
-0.4% -$859 ﹤0.01% 2356
2023
Q1
$207K Sell
41,915
-65
-0.2% -$320 ﹤0.01% 2314
2022
Q4
$229K Buy
41,980
+43
+0.1% +$264 ﹤0.01% 2257
2022
Q3
$273K Buy
41,937
+10,999
+36% +$61.3K ﹤0.01% 2210
2022
Q2
$146K Buy
+30,938
New +$152K ﹤0.01% 2236

Other funds holding MXCT

Mirae Asset Global Investments's MXCT Position: Q4 2025 in Review

Mirae Asset Global Investments sold out of MaxCyte (MXCT) in Q4 2025, closing a stake of 4,121 shares — an estimated $6.51K sold.

Mirae Asset Global Investments first reported a position in MXCT in Q2 2022 and held it in 13 quarters. The position peaked at $273K in Q3 2022. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • Mirae Asset Global Investments reported no remaining MaxCyte position as of Q4 2025 after selling out during the quarter.
  • Mirae Asset Global Investments sold 4,121 MaxCyte shares in Q4 2025, an estimated $6.51K.
  • Mirae Asset Global Investments first reported a position in MaxCyte in Q2 2022 and held it in 13 quarters.
  • Mirae Asset Global Investments's MaxCyte position peaked at $273K in Q3 2022.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on Mirae Asset Global Investments's 13F filing for Q4 2025, filed 26 Jan 2026.